No COVID-19 vaccine before 2021's first quarter, Parliamentary panel told

Published: Jul 11, 2020, 09:49 IST | IANS | New Delhi

Officials cautioned that this is the earliest possible time frame when India can practically have its vaccine

This picture has been used for representation purpose
This picture has been used for representation purpose

As soon as the Parliamentary standing committees started to resume work after a long spell of hibernation, it was not all good news that came in front of them. Notwithstanding the ambitious target set for its market launch, the Standing Committee on Science and Technology was told on Friday that India will have to wait till at least the first quarter of 2021 to get its vaccine that can treat Covid-19. Officials cautioned that this is the earliest possible time frame when India can practically have its vaccine.

Professor Krishnaswamy VijayRaghavan, who is the government's Principal Scientific Advisor, was present in the committee meeting along with representatives from thee Council of Scientific and Industrial Research (CSIR), the Department of Science and Technology and the Department of Biotechnology.

Interestingly, this development comes closely on the heels of India's foremost medical research body, the Indian Council of Medical Research (ICMR), in a letter dated July 3, setting a target to get the vaccine ready by August 15. However, faced with criticism for putting unrealistic pressure, it later clarified saying it was "meant to cut unnecessary red tape, without bypassing any necessary process, and speed up recruitment of participants".

Senior officials told the Parliamentary committee led by Congress MP Jairam Ramesh on Friday that they are hopeful and optimistic about India's chances of inventing the vaccine that will be able to treat the deadly Covid-19. During the proceedings of the committee, certain members were believed to have raised specific questions about recent claims made by yoga guru Ramdev who launched Coronil, claiming it can treat coronavirus, only to retract later.

Meanwhile, researchers in India are all set to start human trials of India's first indigenous coronavirus vaccine candidate - COVAXIN.

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

Sign up for all the latest news, top galleries and trending videos from Mid-day.com

Subscribe
loading image
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK